Role of endothelin-1 in diabetes mellitus

Diabetes/Metabolism Reviews

Volumn 14, Issue 2, 1998, Pages 171-175

  Sármán, Beatrix ^a,b   Tóth, Miklós ^a   Somogyi, Anikó ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NONE   (Hungary)

Author keywords

Atherosclerosis; Diabetes mellitus; Endothelin 1; Insulin; Vasoregulation

Indexed keywords

ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIN-1; HUMANS; RATS;

EID: 0031869227     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199806)14:2<171::AID-DMR207>3.0.CO;2-G     Document Type: Review

References (35)

1. Hickey KA, Rubányi GM, Paul RJ, and High-smith RF: Characterisation of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol 248: C550-556, 1985.
2. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, and Mitsui Y: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
3. Yanagisawa M, Kurihara H, Kimura, S et al.: A novel peptide vasoconstrictor endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J Hypertens (Suppl 6): S188-191, 1988.
4. Hirata Y: Endothelin peptides. Curr Opin Nephr Hyper 5: 12-15, 1996.
5. Levin ER: Endothelins, mechanism of disease. N Engl J Med 333: 356-363, 1995.
6. Cohen RA: The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 38: 105-128, 1995.
7. Fernandez AC, Patino R, and Ibarra J: Endothelin in hypertension and diabetes mellitus. In Endothelin in Cardiovascular Diseases, Lüscher TF, Ed. Springer, Berlin 1995, pp. 157-170.
8. Hu RM, Levin ER, and Pedram A: Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 42: 351-358, 1993.
9. Lien AT, and Reid JJ: Changes in responsiveness to endothelin-1 in isolated atria from diabetic rats. Eur J Pharmacol 261: 33-42, 1994.
10. Loscalzo J: Endothelial injury, vasoconstriction, and its prevention. Tex Heart Inst J 22: 180-184, 1995.
11. Schiffrin EL: The endothelium and control of blood vessel function in health and disease. Clin Invest Med 17: 602-620, 1994.
12. Ferri C, and De-Mattia G: The effect of insulin on endothelin-1 (ET-1) secretion in human cultured endothelial cell. Metabolism 44: 689-690, 1995.
13. Frank HJL, Levin ER, Hu RM, and Pedram A: Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology 133: 1092-1097, 1993.
14. Metsärinne K, Saijonomaa O, Yki-Järvinen H, and Fyhrquist F: Insulin increases the release of endothelial cell cultures in vitro but not in vivo. Metabolism 43: 878-882, 1994.
15. Hattori Y, Kasai K, Nakamura T, Emoto T, and Shimoda S: Effects of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism 40: 165-169, 1991.
16. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, and Nawata H: Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. Febs Lett 267: 16-18, 1990.
17. De la Rubia G, Oliver FJ, Inoguchi T, and King GL: Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retineal pericytes. Diabetes 41: 1533-1539, 1992.
18. Fukui M, Nakamura T, Ebihara I, Makita Y, Osada S, Tomino Y, and Koide H: Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. J Lab Clin Med 123: 763-768, 1994.
19. Ferri C, Carlomagno A, Coassin S, Baldoncini R, and Cassone-Faldetta MR: Circulating endothelin-1 levels increase during euglycemic, hy-perinsulinemic clamp in lean NIDDM men. Diabetes Care 18: 226-233, 1995.
20. Nugent AG, McGurk C, Hayes JR, and Johnston GD: Impaired vasoconstriction to endothelin-1 in patients with NIDDM. Diabetes 45: 105-107, 1996.
21. Morise T, Takeuchi Y, Kawano M, Koni I, and Takeda R: Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 18: 87-89, 1995.
22. Schleiffer T, Nagel D, Franz H, Falk M, Valentiner I, Wildburg G, Stark M, and Brass H: Endothelin and atrial natriuretic peptid in non-insulin-dependent diabetic versus nondiabetic patients on chronic hemodialysis. Renal Fail 16: 747-758, 1994.
23. Donatelli M, Colletti I, Bucalo ML, Russo V, and Verga S: Plasma endothelin levels in NIDDM patients with macroangiopathy. Diabetes Res 25: 159-164, 1994.
24. Kawamura M, Ohgawara H, Naruse M, Suzuki N, Iwasaki N, Naruse K and Hori S: Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 15: 1396-1397, 1992.
25. Kamoi K, Ishibashi M, and Yamaji T: Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy. Diabetes Res Clin Pract 24: 125-129, 1994.
26. Zeng ZP, Tang D, and Sun ML: The relationship between the plasma levels of endothelin and angiopathy in diabetic patients. Chung Hua Nei Ko Tsa Chih 33: 467-469, 1994.
27. Bertello P, Veglio F, Pinna G, Gurioli L, Molino P, Alban S, and Chiandussi L: Plasma endothelin in NIDDM patients with and without complication. Diabetes Care 17: 574-577, 1994.
28. Komatsumoto S, and Nara M: Changes in the level of endothelin-1 with aging. Nippon Ronen Igakkai Zasshi 32: 664-669, 1995.
29. Ferri C, Laurenti O, Bellini C, Faldetta MR, Properzi G, Santucci A, and De-Mattia G: Circulating endothelin-1 levels in lean non-insulin-dependent diabeteic patients: Influence of ACE inhibition. Am J Hypertens 8: 40-71, 1995.
30. Warrens AN, Cassidy MJD, Takahashi K, Ghatei MA, and Bloom SR: Endothelin in renal failure. Nephrol Dial Transplant 5: 418-422, 1990.
31. Smulders RA, Stehouwer CD, Olthof CG, van Kamp GJ, Teerlink T, de Vries PM, and Donker AJ: Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci Colch 87: 37-43, 1994.
32. Collier A, Leach JP, McLellan A, jardine A, Morton JJ, and Small M: Plasma endothelin-like immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 15: 1038-1040, 1992.
33. Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Madaki T, Goto K, Furuichi Y, and Koide H: Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 122: 149-156, 1993.
34. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, and Pagano G: PAI-1 and factor VII activity are higher in IDDM patients with micro-albuminuria. Diabetes 43: 426-429, 1994.
35. Kirilov G, Dakovska L, Borisova AM, Krivoshiev S, and Nentchev N: Increased plasma endothelin levels in patients with insulin-dependent diabetes mellitus and end-stage vascular complications. Horm Metab Res 26: 119-120, 1994.